Related Experiment Video
Updated: May 26, 2026
07:51
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
Fetal outcome in autoimmune diseases
Graziela Carvalheiras1, Raquel Faria, Jorge Braga
1Unidade de Imunologia Clínica, Departamento de Medicina Interna, Hospital de Santo António, Centro Hospitalar do Porto, Porto, Portugal.
Autoimmunity Reviews
|December 27, 2011
Summary
Fetal outcomes in autoimmune diseases depend on maternal immune changes, disease activity, and specific antibodies. While outcomes improve, they remain poorer than in healthy women, emphasizing the need for proactive management.
Area of Science:
- Obstetrics and Gynecology
- Immunology
- Rheumatology
Background:
- Autoimmune diseases significantly impact pregnancy, affecting fetal outcomes due to complex maternal immunological adaptations.
- Key factors influencing fetal success include maternal immune system modifications, disease activity, organ damage, autoantibodies, and medication.
Purpose of the Study:
- To review the impact of autoimmune diseases on fetal outcomes.
- To identify critical factors influencing pregnancy success in women with autoimmune conditions.
- To discuss the role of specific autoantibodies and disease management strategies.
Main Methods:
- Literature review of studies on autoimmune diseases and pregnancy outcomes.
- Analysis of immunological changes, disease-specific risks, and antibody involvement.
- Evaluation of current and future management approaches.
Main Results:
- Autoimmune diseases present a worse prognosis for fetal outcomes compared to healthy pregnancies, despite improvements.
- Antiphospholipid syndrome, systemic lupus erythematosus, and vasculitis carry higher risks.
- Disease activity is a primary determinant of poor fetal outcomes; specific antibodies like antiphospholipid, anti-thyroid, anti-Ro, and anti-La are linked to adverse events.
Conclusions:
- Optimizing fetal outcomes requires meticulous control of autoimmune disease before and during pregnancy.
- Specialized interdisciplinary support is crucial for managing pregnancies in women with autoimmune conditions.
- While challenges persist, proactive disease management offers hope for improved fetal prognosis.
Related Concept Videos
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...